Clinical Research Support
- Cancer Consortium Submission Form (added 09/22/14)
Collects basic information that identifies funding, type of reviews required and information for Core Grant reporting. Completed forms should be submitted to Clinical Research Support.
NOTE: This document replaces the former Cancer Consortium Submission Checklist (version date 12/03/2013) that will be accepted through October 31, 2014. Beginning November 1, 2014, CRS will only accept this new Cancer Consortium Submission Form (version date 09/22/2014 or later).
- Application for Review - Interventional Research
Use for research involving a research intervention with the intent to change the participant. Research involving a clinical intervention, behavioral interventions, dietary interventions, or any other interaction with a living participant with the intent to change their biomedical condition or behavior should use this form.
- Application for Review - Observational Research
Use for research involving interactions with a living participant for the purpose of collecting data or specimens from the participant with no intent to change them. Biospecimen collection, survey research, long term follow-up, observational research, and other data/specimen gathering involving an interaction with a living participant should use this form. Note, if the collection of data or specimens also involves an intervention, use the Interventional Research version of the IRB application.
- Application for Review - Specimen and Data (No Participant Contact) Research
Use for research projects involving human specimens or data where the scope of the research project does not involve interacting with a living participant. Ancilary studies involving specimens or data collected under another research protocol, repositories and coordinating centers with no participant interactions, research involving non-commercially available de-identified specimens/data/cell lines derived from a human, and any other activity involving human specimens or data where there is no interaction with the human. Note, if the collection of data or specimens also involves interaction with a human, use the Observation or Interventional version of the IRB application.
- Approval to Use Radiation with Human Research Subjects
- Continued Approval to use Radiation with Human Research Subjects
- Industry Sponsorship Form
FHCRC industry-sponsored studies only. Gives basic Industry Sponsor information prior to the draft contract.
- IRB Supplements
Links to IRB supplemental forms
- Attachment A (revised 07/18/14)
Application Routing and Review Form
- Attachment A Instructions (revised 07/18/14)
How to complete the Attachment A
- UW/CC - IRB coversheet and review authorization
UW Consortium CC-IRB submissions only
- UW/WIRB Coversheet
UW Consortium WIRB submissions only
- External Performance Site Feasibility Checklist
Cancer Consortium submissions that require EPSAC review
- Clinical Trial Activity Summary (CTAS) (revised 03/12/14)
A Clinical Trial Activity Summary (a.k.a. Activity Summary) is required for all therapeutic and diagnostic studies submitted to the Research Implementation Office (RIO) for research pricing and/or implementation review for services occurring at SCCA as of Sept. 1, 2012. The primary purpose of the Activity Summary is for facilitating the financial clearance process for clinical trials.